Skip to main content

Table 1 Patient characteristics

From: Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial

 

Sex

FEV1 (%)

Age (yrs)

BMI

LTOT

Comorbidities

Drug sequence

1

M

35.5

59

31

HT, CAD, DM, LPR

NaCl, morphine

2

M

29.2

73

14

PAF, Anemia

Morphine, NaCl

3

M

29.7

59

23

HT

Morphine, NaCl

4

M

22.2

63

32

Yes

HT, DM

Morphine, NaCl

5

M

24.2

83

16

HT, CAD

Morphine, NaCl

6

M

28.7

62

26

TR, MR, OSA

NaCl, morphine

7

M

17.4

60

25

NaCl, morphine

8

M

28.6

74

23

NaCl, morphine

9

F

28.0

72

27

Yes

HT

Morphine, NaCl

10

F

31.0

67

30

Yes

GERD

NaCl, morphine

Mean

27.5%

67.2

24.7